Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999–2009

BACKGROUND: Artemisinin-based combination therapy (ACT) is the recommended first-line therapy for uncomplicated Plasmodium falciparum malaria worldwide but decreased artemisinin susceptibility, phenotypically characterized as slow parasite clearance time (PCT), has now been reported in Southeast Asi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Zwang, Julien, Dorsey, Grant, Mårtensson, Andreas, d’Alessandro, Umberto, Ndiaye, Jean-Louis, Karema, Corine, Djimde, Abdoulaye, Brasseur, Philippe, Sirima, Sodiomon B, Olliaro, Piero
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3987158/
https://ncbi.nlm.nih.gov/pubmed/24666562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-13-114
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi